Thrombotic thrombocytopenic purpura: pathophysiology, diagnosis, and management

S Sukumar, B Lämmle, SR Cataland - Journal of clinical medicine, 2021 - mdpi.com
Thrombotic thrombocytopenic purpura (TTP) is a rare thrombotic microangiopathy
characterized by microangiopathic hemolytic anemia, severe thrombocytopenia, and …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the writing committee of the American society for apheresis: the …

J Schwartz, A Padmanabhan, N Aqui… - Journal of clinical …, 2016 - Wiley Online Library
The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA) Special
Issue Writing Committee is charged with reviewing, updating, and categorizing indications …

Guidelines on the Use of therapeutic apheresis in clinical practice–Evidence‐Based approach from the Writing Committee of the American Society for Apheresis: The …

L Connelly‐Smith, CR Alquist, NA Aqui… - Journal of clinical …, 2023 - Wiley Online Library
Abstract The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating, and categorizing …

Guidelines on the use of therapeutic apheresis in clinical practice–evidence‐based approach from the Writing Committee of the American Society for Apheresis: the …

A Padmanabhan, L Connelly‐Smith… - Journal of clinical …, 2019 - Wiley Online Library
ABSTRACT The American Society for Apheresis (ASFA) Journal of Clinical Apheresis (JCA)
Special Issue Writing Committee is charged with reviewing, updating and categorizing …

Thrombotic thrombocytopenic purpura

JA Kremer Hovinga, P Coppo, B Lämmle… - Nature reviews Disease …, 2017 - nature.com
Thrombotic thrombocytopenic purpura (TTP; also known as Moschcowitz disease) is
characterized by the concomitant occurrence of often severe thrombocytopenia …

Epidemiology and pathophysiology of adulthood-onset thrombotic microangiopathy with severe ADAMTS13 deficiency (thrombotic thrombocytopenic purpura): a cross …

E Mariotte, E Azoulay, L Galicier, E Rondeau… - The Lancet …, 2016 - thelancet.com
Background Thrombotic thrombocytopenic purpura is a thrombotic microangiopathy related
to a severe deficiency of ADAMTS13 (a disintegrin and metalloprotease with …

[HTML][HTML] Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics

M Saha, JK McDaniel, XL Zheng - Journal of Thrombosis and Haemostasis, 2017 - Elsevier
Thrombotic thrombocytopenic purpura (TTP), a potentially fatal clinical syndrome, is
primarily caused by autoantibodies against the von Willebrand factor (VWF)‐cleaving …

Drug-induced thrombotic microangiopathy: an updated review of causative drugs, pathophysiology, and management

T Mazzierli, F Allegretta, E Maffini… - Frontiers in …, 2023 - frontiersin.org
Drug-induced thrombotic microangiopathy (DITMA) represents 10%–13% of all thrombotic
microangiopathy (TMA) cases and about 20%–30% of secondary TMAs, just behind …

Society of Interventional Radiology consensus guidelines for the periprocedural management of thrombotic and bleeding risk in patients undergoing percutaneous …

JC Davidson, S Rahim, SE Hanks… - Journal of vascular …, 2019 - pubmed.ncbi.nlm.nih.gov
Society of Interventional Radiology Consensus Guidelines for the Periprocedural
Management of Thrombotic and Bleeding Risk in Patients Undergoing Percutaneous Image-Guided …

Drug-induced glomerular disease: direct cellular injury

GS Markowitz, AS Bomback… - Clinical journal of the …, 2015 - journals.lww.com
The potential of medications to cause kidney injury is well known. Although nephrotoxicity is
most commonly associated with injury in the tubulointerstitial compartment as either acute …